EM
Encore MedicalEncore Medical develops transcatheter septal occlusion devices to repair structural heart defects like patent foramen ovale (PFO).
2 Pulse stories
FT
Flare TherapeuticsFlare Therapeutics is a clinical-stage biotech developing small-molecule drugs that target transcription factors, including a first-in-class ARON-targeting degrader for prostate cancer.
2 Pulse stories
Total Raised
$290M
Encore MedicalFlare Therapeutics
Last ValuationNot disclosed
Biotech
Sector
Biotech
2017
Founded
2021
Eagan, Minnesota
HQ
Cambridge, Massachusetts
Public (EMI)
Status
Private
Encore Medical investors
No investors on record.
Flare Therapeutics investors
Third Rock VenturesNextech InvestPfizer VenturesBoxer CapitalGordonMD Global InvestmentsInvusCasdin CapitalEli Lilly and Company
Data from Value Add Pulse coverage and company research — see the full threads for Encore Medical and Flare Therapeutics.